Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D. Issue 5 (13th November 2015)

• Record Type: Journal Article
• Authors: Fouad, Rabab; Abdo, Mahmoud; Eldeen, Hadeel Gamal; Sabry, Dina; Atef, Mira; Ahmed, Rasha; Zayed, Naglaa
• Is Part Of: Journal of medical virology. Volume 88:Issue 5(2016)
• Page Start: 837
• Page End: 842
• Publication Date: 2015-11-13
• Subjects: HDV -- HBV -- genotype -- Egypt; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.24412
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract : Hepatitis delta virus (HDV) usually have an unfavorable clinical outcome in chronic hepatitis B virus (HBV) patients. In Egypt, data about epidemiology, the spectrum of disease, and impact of HDV on HBV infection are rare. To assess the prevalence, clinical and virological characteristics of HDV infection among Egyptian patients with chronic HBV. Adult patients with Hepatitis B surface antigen (HBsAg)‐positive were evaluated for the presence of HDV using anti HDV‐IgG and HDV RNA by RT‐PCR. Routine laboratory investigations, genotypes and subtypes for both HBV and HDV, abdominal sonography, and transient elastography (TE) were done. Liver biopsy was performed only in whenever indicated. One hundred and twenty‐one treatment‐naïve chronic HBV patients were included. Wild HBV genotype‐D2 was found in 98.2% and 81.9% were HBeAg negative. Prevalence of HDV was 8.3% by anti‐HDV IgG and 9.9% by RT‐PCR. Wild HDV genotype‐IIb was reported in 83.3%. HDV infection was more common in males, 90.9% of delta patients were HBeAg negative. Compared to the mono‐infected HBV, concomitant HBV/HDV infection was not associated with more derangment in ALT nor advanced stage of fibrosis. 66.7% of HDV patients had significantly lower HBV‐DNA level compared to the non‐delta patients ( P < 0.001). HDV is not uncommon in Egypt. HBV genotype‐D was associated with HDV genotype‐IIb. Delta infection was associated with negative HBeAg status, reduction of HBV replication, but neither influenced the clinical course nor increased significant liver damage risk. J. Med. Virol. 88:837–842, 2016 . © 2015 Wiley Periodicals, Inc.